Wei-Ding Wu (Weiding Wu)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Cell Proliferation

Long Non Coding Rna

Top Venues

Cell death & disease

International journal of cancer

The FEBS journal

This page only lists publications with an associated author ORCID identifier.

Publications

Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Hui-Ru Zhang, Tian-Jiao Li, Xian-Jun Yu, Chen Liu, Wei-Ding Wu, Long-Yun Ye, Kai-Zhou Jin
The GFPT2-O-GlcNAcylation-YBX1 axis promotes IL-18 secretion to regulate the tumor immune microenvironment in pancreatic cancer. Cell death & disease 15 (4) (2024)
Zhenyu Liao, Longyun Ye, Tianjiao Li, Xing Jin, Xuan Lin, Qinglin Fei, Huiru Zhang, Saimeng Shi, Xianjun Yu, Kaizhou Jin, Wei-Ding Wu
Tissue-resident CXCR4 + macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. International journal of cancer (2023)
Saimeng Shi, Duancheng Guo, Longyun Ye, Tianjiao Li, Qing-Lin Fei, Mengxiong Lin, Xian-Jun Yu, Kai-Zhou Jin, Wei-Ding Wu
Knockdown of TACC3 inhibits tumor cell proliferation and increases chemosensitivity in pancreatic cancer. Cell death & disease 14 (11) (2023)
Zhenyu Liao, Longyun Ye, Tianjiao Li, Xing Jin, Xuan Lin, Qinglin Fei, Huiru Zhang, Saimeng Shi, Xianjun Yu, Kaizhou Jin, Wei-Ding Wu
Tissue-resident CXCR4 + macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. International journal of cancer (2023)
Kai-Zhou Jin, Ying Wu, Xiao-Xiao Zheng, Tian-Jiao Li, Zhen-Yu Liao, Qing-Lin Fei, Hui-Ru Zhang, Sai-Meng Shi, Xin Sha, Xian-Jun Yu, Wei Chen, Long-Yun Ye, Wei-Ding Wu
Inhibition of Epithelial-to-Mesenchymal Transition Augments Antitumor Efficacy of Nanotherapeutics in Pancreatic Ductal Adenocarcinoma. The FEBS journal (2023)